Gordon A. Gardiner - 24 Nov 2021 Form 4/A - Amendment Insider Report for CytoDyn Inc. (CYDY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4/A - Amendment
Accepted by SEC
30 Nov 2021, 17:31:07 UTC
Original report date
29 Nov 2021
Prior SEC filing
20 Oct 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Antonio Migliarese, Attorney-In-Fact Signature of Reporting Person

Key filing fact

Gordon A. Gardiner filed Form 4/A - Amendment for CytoDyn Inc. (CYDY) on 30 Nov 2021.

Key facts

  • This page summarizes Gordon A. Gardiner's Form 4/A - Amendment filing for CytoDyn Inc. (CYDY).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 30 Nov 2021, 17:31.

Change

  • Previous filing in this sequence was filed on 20 Oct 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYDY transaction Derivative

Non-qualified Stock Option

Disposed to Issuer

Transaction value
Shares
-225,000
Change %
-100%
Price
Shares after
0
Date
24 Nov 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
225,000
Exercise price
$1.39
Footnotes
F1
CYDY transaction Derivative

Non-qualified Stock Option

Award

Transaction value
Shares
+93,750
Change %
Price
Shares after
93,750
Date
24 Nov 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
93,750
Exercise price
$1.39
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Gordon A. Gardiner is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, the stock option granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .